Data is more than just a hot topic; everyone is focusing on how they can better gather, handle and manipulate […]
The largest ever survey looking at global public perceptions of genomic data sharing suggests that more work is needed to […]
Recently, we have been posting about the changes in user perceptions on the way genetic data is owned, handled, and […]
Many pharmaceutical companies are switching their focus to collecting, analysing and learning from large data sets. In fact, in early […]
With the cost of developing a drug doubling every 9 years, the pharma business model will soon become largely unsustainable. […]
We are seeing an increased interest in the examination of multiple omics layers, to paint in-depth molecular pictures that can […]
Despite the rise in COVID-19 cases and deaths, hopes for a vaccine have become more of a reality. Here, we […]
Making Space for Biomarker Data Clinical research, particularly cancer diagnostics, has seen an explosion in the collection of biomarker data […]
As genomic sequencing becomes more routine, handling the sheer volume of data being produced is causing major issues. We must […]
Sano Genetics, Zetta Genomics and Genomics England have partnered to develop a novel system to allow rare disease patients and […]
